Kidney Transplant Outcomes and APOL1
肾移植结果和 APOL1
基本信息
- 批准号:9441559
- 负责人:
- 金额:$ 28.68万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-25 至 2021-05-31
- 项目状态:已结题
- 来源:
- 关键词:APOL1 geneAcuteAdultAffectAfricanAfrican AmericanAlbuminuriaAllelesAllograftingBasic ScienceBloodCaucasiansChildhoodChronicChronic Kidney FailureClinicalClinical ResearchComorbidityCreatinineCytomegalovirusDNADataDatabasesDeteriorationDiagnosticDialysis procedureDiseaseDisease ProgressionEnd stage renal failureEnvironmental ExposureFunctional disorderFutureGSTM1 geneGenesGenetic RiskGenetic VariationGenetic studyGenotypeGlomerular Filtration RateGoalsGraft SurvivalGrowthHealthHepatitis BHepatitis CHeritabilityHuman Herpesvirus 4HypertensionImmune systemImmunizationIncidenceIndividualKidneyKidney DiseasesKidney FailureKidney TransplantationLeadLiving DonorsMicroalbuminuriaOrganOrgan ProcurementsOrgan TransplantationOther GeneticsOutcomePatientsPopulationQuality of lifeRNARecruitment ActivityRenal Replacement TherapyRenal functionResearchResourcesRiskRisk FactorsRoleScienceSeveritiesSickle Cell TraitSiteSpecimenSubgroupSystemTherapeuticTimeTranslational ResearchTransplant RecipientsTransplantationUnited Network for Organ SharingUnited StatesUrineVirus DiseasesWaiting Listscaucasian Americanclinically relevantcostfollow-upgene environment interactiongene interactiongenetic risk factorgraft failurehigh riskimprovedinsightmortalitymultidisciplinarypolicy implicationprognosticprospectiveprotocol developmentrate of changerepositoryresponserisk varianttrait
项目摘要
PROJECT SUMMARY
Chronic kidney disease (CKD) affects >10% of the adult US population, costs tens of billions of dollars
annually, and can lead to progressive kidney failure leading to need for renal replacement therapy. Successful
kidney transplant reverses many of the chronic abnormalities in CKD and has shown to improve not only quality
of life but also patient survival compared to renal replacement therapy. It is vital to identify strategies that
improve and prolong organ function. We have established a multidisciplinary investigative team and outline
plans for a multicenter transplant prospective recruiting clinical center for the RFA-DK-16-025 – “APOL1 Long-
term Kidney Transplantation Outcomes Network (APOLLO) Clinical Centers”, to assess the outcome of kidney
transplant recipients and living donors in relation to the African-ancestry APOL1 alleles. APOL1 risk alleles
have been shown to explain a large part of the increased risk of African Americans compared to non-African
American for end-stage renal disease. However, the association of APOL1 alleles with kidney transplant
outcomes such as deterioration of kidney function, acute rejection, and allograft loss as well as living donor
health is unclear. We propose to assess if the presence of APOL1 donor risk alleles is associated with kidney
transplant outcomes (rate of change of kidney function, rates of acute rejection and graft failure defined as re-
transplantation, initiation of dialysis or GFR < 15 ml/min/1.73m2) (Aim 1); to determine if acute rejection, viral
infections and other genetic factors in the donor-recipient pair alters the impact of donor APOL1 risk alleles with
kidney transplant outcomes (Aim 2); and determine the impact of kidney donation in African American donors
with APOL1 risk alleles with up to 3.5 years of longitudinal follow-up (Aim 3). We are committed to collaborative
protocol development, sharing best practices, and team science to achieve the APOLLO's objectives. The
APOLLO network will also establish a high quality resource (data and specimen repository of blood, urine,
DNA, and RNA) for future basic, clinical and translational research in transplantation. The proposed research
plan will have future diagnostic, prognostic and therapeutic implications. In addition, it could have policy
implications as kidneys may need to be allocated in the future taking into account the donor APOL1 genotype.
项目摘要
慢性肾脏疾病(CKD)影响超过10%的美国成年人口,花费数百亿美元
每年发生一次,并可能导致进行性肾衰竭,从而需要肾脏替代治疗。成功
肾移植逆转了CKD的许多慢性异常,
与肾脏替代治疗相比,至关重要的是确定战略,
改善和延长器官功能。我们已经建立了一个多学科的调查小组,
RFA-DK-16-025 -“APOL 1长-
术语肾移植结局网络(APOLLO)临床中心”,以评估肾移植的结局。
移植受者和活体捐赠者与非洲血统APOL 1等位基因的关系。APOL 1危险等位基因
已经被证明可以解释非洲裔美国人与非非洲裔美国人相比风险增加的很大一部分。
美国人称之为终末期肾病然而,APOL 1等位基因与肾移植的关联
结果如肾功能恶化、急性排斥反应和同种异体移植物丢失以及活体供者
健康状况不明。我们建议评估APOL 1供体风险等位基因的存在是否与肾脏疾病相关。
移植结果(肾功能变化率、急性排斥反应率和移植物衰竭定义为再
移植、开始透析或GFR < 15 ml/min/1.73m2)(目的1);以确定是否存在急性排斥、病毒性排斥、
供体-受体对中的感染和其他遗传因素改变了供体APOL 1风险等位基因的影响,
肾移植结果(目标2);并确定非裔美国人供体肾脏捐赠的影响
具有APOL 1风险等位基因,纵向随访长达3.5年(目标3)。我们致力于合作
协议开发,分享最佳实践和团队科学,以实现APOLLO的目标。的
APOLLO网络还将建立高质量资源(血液、尿液、
DNA和RNA)用于移植的未来基础、临床和转化研究。拟议研究
该计划将对未来的诊断、预后和治疗产生影响。此外,它还可以制定政策,
这意味着将来可能需要考虑供体APOL 1基因型来分配肾脏。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sylvia E Rosas其他文献
Sylvia E Rosas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Sylvia E Rosas', 18)}}的其他基金
Boston Chronic Kidney Disease Research Biopsy Center
波士顿慢性肾脏病研究活检中心
- 批准号:
10704109 - 财政年份:2022
- 资助金额:
$ 28.68万 - 项目类别:
Boston Chronic Kidney Disease Research Biopsy Center
波士顿慢性肾脏病研究活检中心
- 批准号:
10493645 - 财政年份:2022
- 资助金额:
$ 28.68万 - 项目类别:
Harvard Chronic Kidney Disease Research Biopsy Center
哈佛慢性肾脏病研究活检中心
- 批准号:
10223910 - 财政年份:2017
- 资助金额:
$ 28.68万 - 项目类别:
Harvard Chronic Kidney Disease Research Biopsy Center
哈佛慢性肾脏病研究活检中心
- 批准号:
9910985 - 财政年份:2017
- 资助金额:
$ 28.68万 - 项目类别:
9/14 APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) Clinical Center
9/14 APOL1 长期肾移植结果网络 (APOLLO) 临床中心
- 批准号:
10731303 - 财政年份:2017
- 资助金额:
$ 28.68万 - 项目类别:
Harvard Chronic Kidney Disease Research Biopsy Center
哈佛慢性肾脏病研究活检中心
- 批准号:
9394445 - 财政年份:2017
- 资助金额:
$ 28.68万 - 项目类别:
Carotid Intima-Media Thickness in Chronic Kidney Disease: a CRIC ancillary study
慢性肾病中的颈动脉内膜中层厚度:CRIC 辅助研究
- 批准号:
7991408 - 财政年份:2009
- 资助金额:
$ 28.68万 - 项目类别:
Carotid Intima-Media Thickness in Chronic Kidney Disease: a CRIC ancillary study
慢性肾病中的颈动脉内膜中层厚度:CRIC 辅助研究
- 批准号:
8300240 - 财政年份:2008
- 资助金额:
$ 28.68万 - 项目类别:
相似海外基金
Un/kindness, shame & resistance: the care of inpatients in NHS adult acute mental health units and how it might be improved
Un/善良,羞耻
- 批准号:
2885806 - 财政年份:2023
- 资助金额:
$ 28.68万 - 项目类别:
Studentship
Post-Acute Care Transitions for Older Adult Medicare Beneficiaries with Serious Mental Illness
患有严重精神疾病的老年医疗保险受益人的急性后护理过渡
- 批准号:
10772386 - 财政年份:2023
- 资助金额:
$ 28.68万 - 项目类别:
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
474619 - 财政年份:2022
- 资助金额:
$ 28.68万 - 项目类别:
Operating Grants
Investigating the impact acute inhalation of cannabis with a high content of delta-9-tetrahydrocannabinol has on myelination and microglia in adult and aged mice
研究急性吸入高含量 delta-9-四氢大麻酚的大麻对成年和老年小鼠髓鞘形成和小胶质细胞的影响
- 批准号:
485965 - 财政年份:2022
- 资助金额:
$ 28.68万 - 项目类别:
Studentship Programs
Paving The Way to a Canadian Standard of Care with CAR-T Cellular Therapy: Phase II Trial of CD19 CAR-T for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia (CLIC-01A)
通过 CAR-T 细胞疗法为加拿大护理标准铺平道路:CD19 CAR-T 治疗复发/难治性成人急性淋巴细胞白血病的 II 期试验 (CLIC-01A)
- 批准号:
466358 - 财政年份:2022
- 资助金额:
$ 28.68万 - 项目类别:
Operating Grants
Metabolomics for prediction of cisplatin mediated acute kidney injury: a Canadian multi-centre adult and pediatric study
预测顺铂介导的急性肾损伤的代谢组学:加拿大多中心成人和儿童研究
- 批准号:
402040 - 财政年份:2019
- 资助金额:
$ 28.68万 - 项目类别:
Operating Grants
Study of pathogenic mechanism of age-dependent chromosome translocation in adult acute lymphoblastic leukemia
成人急性淋巴细胞白血病年龄依赖性染色体易位发病机制研究
- 批准号:
18K16103 - 财政年份:2018
- 资助金额:
$ 28.68万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Causal effect of time-varying driving pressures on mortality in mechanically ventilated, adult patients with acute respiratory distress syndrome
时变驱动压力对机械通气成年急性呼吸窘迫综合征患者死亡率的因果影响
- 批准号:
377313 - 财政年份:2017
- 资助金额:
$ 28.68万 - 项目类别:
Studentship Programs
Role of SETBP1 in adult Ph+ acute lymphoblastic leukemia
SETBP1 在成人 Ph 急性淋巴细胞白血病中的作用
- 批准号:
9315111 - 财政年份:2016
- 资助金额:
$ 28.68万 - 项目类别:
Acute Inhibition of Adult-born Granule Cells and its Effect on Antidepressant Act
成体颗粒细胞的急性抑制及其抗抑郁作用
- 批准号:
8734273 - 财政年份:2013
- 资助金额:
$ 28.68万 - 项目类别: